trending Market Intelligence /marketintelligence/en/news-insights/trending/I8QBaB51yq6Djw1KxP0TjA2 content esgSubNav
In This List

LifeWatch board approves improved BioTelemetry offer

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Perspectives from China: Chinese M&A in 2022

Blog

Insight Weekly: CEO pay jumps; yield curve inversion deepens; wind giants lift turbine prices


LifeWatch board approves improved BioTelemetry offer

The board of Switzerland-based digital health services provider LifeWatch AG unanimously agreed to accept BioTelemetry Inc.'s improved public takeover offer.

The LifeWatch board concluded that the improved price is fair and adequate, and the deal is in the best interest of the company, LifeWatch said in a news release.

Further, Aevis Victoria SA and Himalaya TMT Fund intend to accept the increased offer.

BioTelemetry recently raised its offer price for LifeWatch to CHF269 million from CHF260 million and extended the offer period to June 8 from May 31. The deal will be transacted through BioTelemetry unit Cardiac Monitoring Holding Co. LLC.